Jessica Treat, APRN
Pulmonary Disease · Hot Springs, ARNPI 1043840457
Payments from drug & device makers
Across 637 payments — averaging $19.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- GSK$2K
- Boehringer Ingelheim$1K
- Mallinckrodt Hospital Products Inc.$1K
- Grifols USA, LLC$796
- Regeneron Healthcare Solutions, Inc.$718
- plus $4K from 24 others
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 125 | $2,507 |
| GSK | 133 | $2,160 |
| Boehringer Ingelheim | 52 | $1,054 |
| Mallinckrodt Hospital Products Inc. | 43 | $1,030 |
| Grifols USA, LLC | 43 | $796 |
| Regeneron Healthcare Solutions, Inc. | 39 | $718 |
| Sanofi | 37 | $685 |
| Actelion Pharmaceuticals US, Inc. | 11 | $476 |
| Takeda Pharmaceuticals U.S.A., Inc. | 22 | $418 |
| Electromed, Inc. | 15 | $380 |
| Paratek Pharmaceuticals, Inc. | 12 | $349 |
| Mylan Specialty L.p. | 19 | $338 |
| Philips North America LLC | 12 | $227 |
| Insmed, Inc. | 12 | $218 |
| Baxter Healthcare | 11 | $189 |
| Verona Pharma, Inc. | 11 | $168 |
| Viatris Specialty LLC | 9 | $157 |
| Vifor Pharma, Inc. | 7 | $129 |
| United Therapeutics Corporation | 5 | $124 |
| Sanofi-aventis U.S. LLC | 1 | $98 |
| Inogen, Inc. | 4 | $53 |
| ANI Pharmaceuticals, Inc. | 2 | $48 |
| Genentech USA, Inc. | 3 | $47 |
| Advanced Respiratory, Inc | 2 | $42 |
| Amgen | 2 | $41 |
| AbbVie | 1 | $30 |
| Novartis | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $14 |
| Liquidia Technologies, Inc. | 1 | $14 |
How this compares
$12,553 in reported general payments places this provider in the 80th percentile of 102 pulmonary disease providers in Arkansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Hot Springs
- Albert ChinnHot Springs$7K
- Anupama KaulHot Springs$5K
- Jovan GayleHot Springs$5K
- Jarmil PetersHot Springs$3K
- Larry JohnsonLittle Rock$847K
- Timothy CookSherwood$638K
- Nikhil MeenaLittle Rock$574K
- Raghu ReddyLittle Rock$541K
- Ladly AbrahamConway$521K
- Daniel PaulRogers$244K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.